期刊文献+

氨磷汀与放射性肺损伤中肺剂量体积因素V_(20)的关系 被引量:1

Relationship between amifostine and lung dose volume factor V_(20) in radiation-induced lung injury
下载PDF
导出
摘要 目的建立氨磷汀干预下^(60)Co-γ放射性肺损伤大鼠模型,并探讨氨磷汀在放射性肺损伤剂量体积因素V_(20)=25%和V_(20)=35%条件下发生肺损伤的作用。方法雄性SD大鼠随机分为空白组、模型组Ⅰ(照射V_(20)=25%)、模型组Ⅱ(照射V_(20)=35%)、药物干预组Ⅰ(氨磷汀+照射V_(20)=25%)、药物干预组Ⅱ(氨磷汀+照射V_(20)=35%)。模型组、药物干预组用^(60)Co-γ射线对大鼠右肺进行照射,于照射后第1,2,4,8和12周末处死大鼠,腹主动脉取血,ELISA法测定血清中转化生长因子β1(TGF-β_1)含量;同时间点取照射后肺组织,HE、Massons染色观察肺组织的病理损伤变化。结果与空白组比较,模型组大鼠肺泡壁增厚,肺泡间质大部分为增生纤维组织和弹力纤维组织,血清TGF-β_1显著升高(P<0.05);与模型组比较,大鼠肺组织在药物干预组(V_(20)分别为25%和35%)出现肺泡壁增厚和纤维化的时间滞后且程度轻,仍见大部分正常肺泡结构,且血清TGF-β_1明显降低(P<0.05);模型组Ⅱ中大鼠肺组织病理损伤和血清TGF-β_1均高于模型组Ⅰ,而其在药物干预组Ⅰ和Ⅱ之间未见显著改变。结论氨磷汀能减轻放射性肺损伤发生的概率,对V_(20)限定值可适当提高。 Objective To establish an animal model of lung ^(60)Co-γ radiation injury caused by amifostine and to investigate the effect of amifostine on lung injury in the lung dose volume factor 25% and 35%. Methods SD male rats were randomly divided into control group,model group Ⅰ( radiation with V_(20)= 25% and no amifostine),model group Ⅱ( radiation with V_(20)= 35% and no amifostine),drug intervention group Ⅰ( radiation with V_(20)= 25% and amifostine),and drug intervention group Ⅱ( radiation with V_(20)= 35% and amifostine). The rats in model groups and drug intervention groups were irradiated with ^(60)Co-gamma on the right lung. The blood and irradiated lungs from rats were collected at the end of 1,2,4,8 and 12 weeks after irradiation. The levels of transforming growth factor-beta 1( TGF-β_1) were determined using ELISA. The pathological damage of lung tissues was assessed using HE and Massons staining. Results The alveolar wall was thicker,and there was more hyperplasia fibrous tissues and elastic fiber tissues in the alveolar interstitial in model groups than in control group. The levels of TGF-β_1 in model groups were increased significantly compared with control group( P 〈0. 05). The appearance time of the thicken alveolar wall and lung fibrosis in drug intervention groups( V_(20)= 25% and 35%) was lagged compared with model groups. Moreover,the pathological damage of lung tissues in drug intervention groups was slighter than that in model groups. The levels of TGF-β_1in drug intervention groups were decreased compared to model group( P 〈0. 05). The degree of pathological injury in model group Ⅱ was more severe than that in model group Ⅰ. The levels of TGF-β_1 in model group Ⅱ were higher than those in model group Ⅰ. However,the degree of pathological injury and the levels of TGF-β_1 showed no significant difference between drug intervention groups Ⅰ and Ⅱ. Conclusion Amifostine can reduce the incidence of radiationinduced lung injury and the amifostine may appropriately increase the V_(20) limit value.
作者 郑保珍 陈朝阳 王天奇 王海龙 庞敏 郭民 ZHENG Baozhen CHEN Zhaoyang WANG Tianqi WANG Hailong PANG Min GUO Min(Department of Thoracic Radiothera- py, Shanxi Tumor Hospital, Taiyuan 030013, China Laboratory Animal Center of Shanxi Medical University, Shanxi Key Laboratory of Experimental Animals and Animal Models for Human Diseases Department of Anesthesiology, Second Hospital of Shanxi Medical University Department of Respiration, First Hospital of Shanxi Medical University)
出处 《山西医科大学学报》 CAS 2017年第7期671-675,共5页 Journal of Shanxi Medical University
基金 山西省科技攻关基金资助项目(20130313017-5)
关键词 氨磷汀 放射性肺损伤 肺剂量体积因素 转化生长因子 amifostine radiation-induced lung injury lung dose volume factor transforming growth factor
  • 相关文献

参考文献3

二级参考文献29

  • 1Mcdonald S,Rubin P,Phillips TL,et al.Injury to the lung from cancer therapy:clinical syndromes,measurable endpoints,and potential scoring systems.Int J Radiat Oncol Biol Phys,1995,31:1187-1203.
  • 2Rubin P,Johnston CJ,Williams JP,et al.A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis.Int J Radiat Ocol Biol Phys,1995,33:99-109.
  • 3Marks LB,Yu XL,Vujaskovic Z,et al.Radiation-induced lung injury.Semin Radiat Oncol,2003,13:333-345.
  • 4Cromwell O,Hamid Q,Corrigan CJ,et al.Expression and generation of interleukin-8,IL-6 and granulocyte macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-lband tumor necrosis factor a.Immunology,1992,77:330-337.
  • 5Crestani B,Comillet P,Dehoux M,et al.Alveolar type Ⅱ epithelial cells produce interleukin-6 in vitro and in vivo.J Clin Invest,1994,94:731-740.
  • 6Arnold R,Humbert B,Werchau H,et al.Interleukin-8,interleukin-6,and soluble tumor necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus.Immunology,1994,82:126-133.
  • 7Elias JA,Lentz V,Cummings P.Transforming growth factor-b regulation of IL-6 production by unstimulated and IL-1 stimulated human fibroblasts.J Immunol,1991,146:3437-3443.
  • 8Hirano T.Interleukin-6 and its relation to inflammation and disease.Clin Immunol Immunopathol,1992,62:s60-s65.
  • 9Yoshida M,Sakuma J,Hayashi S,et al.A histologically distinctive interstitial pneumonia induced by over expression of the interleukin 6,transforming growth factor beta 1,or platelet-derived growth factor B gene.Proc Nall Acad Sci USA,1995,92:9570-9574.
  • 10Gibson PG,Bryant DH,Morgan GW,et al.Radiation-induced lung injury:a hypersensitivity pneumonitis? Ann Intern Med,1988,109:288-291.

共引文献49

同被引文献8

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部